Guillain-Barr é syndrome in patients dying with COVID-19 in Italy: a retrospective study
CONCLUSIONS: Although the mechanism of GBS onset is still unclear in COVID-19, fatal cases may be more frequent than other virus-related GBS, so that strictly monitoring in high-risk patients could dramatically decrease the mortality of GBS.PMID:37712236 | DOI:10.4415/ANN_23_03_04
Source: Ann Ist Super Sanita - Category: Biomedical Science Authors: Elisa Colaizzo Maria Puopolo Dorina Tiple Luana Vaianella Nicola Vanacore Alberto Milanese Luigi Palmieri Cinzia Lo Noce Marco Canevelli Alessia Perna Graziano Onder Italian National Institute of Health COVID-19 Mortality Group Source Type: research
More News: Biomedical Science | COVID-19 | CT Scan | Cytology | Guillain-Barr Syndrome | Intensive Care | Italy Health | PET Scan | Pneumonia | Study | X-Ray